CEL-SCI Corporation logo

CEL-SCI Corporation

AMEX:CVM

Overview | Financials
Company Name CEL-SCI Corporation
Symbol CVM
Currency USD
Price 2.18
Market Cap 103,027,018
Dividend Yield 0%
52-week-range 1.04 - 3.33
Industry Biotechnology
Sector Healthcare
CEO Mr. Geert R. Kersten Esq.
Website https://cel-sci.com

An error occurred while fetching data.

About CEL-SCI Corporation

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented

Related Stocks

Stereotaxis, Inc. logo

Stereotaxis, Inc.

STXS

1.56 USD

Retractable Technologies, Inc. logo

Retractable Technologies, Inc.

RVP

1.08 USD

Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc.

ATNM

4.49 USD

VolitionRx Limited logo

VolitionRx Limited

VNRX

0.748 USD

Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc.

MTNB

0.235 USD

Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc.

ARMP

2.22 USD

Cybin Inc. logo

Cybin Inc.

CYBN

0.45 USD

Electromed, Inc. logo

Electromed, Inc.

ELMD

10.5 USD

InfuSystem Holdings, Inc. logo

InfuSystem Holdings, Inc.

INFU

9.29 USD

Asensus Surgical, Inc. logo

Asensus Surgical, Inc.

ASXC

0.236 USD

Financials

Numbers are in millions USD

Numbers are in millions USD